Lantheus Holdings

LNTH83

High Quality

$90.52arrow_drop_up3.63%$3.17

High Quality

LNTH83

$90.52

arrow_drop_up3.63%$3.17

High Quality

Performance History

Key Stats
Open	$88.60
Prev. Close	$87.32
EPS	6.02
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	86.03	90.96
52 Week Range	50.20	126.89

Ratios







EPS	6.02

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Lantheus Holdings (LNTH)

Lantheus Holdings Inc (LNTH) operates as a worldwide leader in the development, manufacture, and commercialization of innovative diagnostic medical imaging agents and products. The company offers a diverse portfolio of products, including contrast agents used in cardiac imaging, radiopharmaceuticals used in molecular imaging, and nuclear imaging systems. With a focus on precision medicine, Lantheus delivers solutions that enable healthcare professionals to make more confident diagnostic and treatment decisions for their patients.

In recent news, Lantheus Holdings announced its financial results for the first quarter of 2021. The company reported total revenue of $79.3 million, representing a 6% increase compared to the same period last year. This growth was primarily driven by higher sales of its DEFINITY and TechneLite products. Additionally, Lantheus expanded its global reach through key partnerships and collaborations, further strengthening its position in the market.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Ms. Mary Anne Heino
Headquarters: Bedford
Employees: 698
Exchange: NASDAQ

Keep an eye on Lantheus Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for Lantheus Holdings (LNTH)?

For Lantheus Holdings (LNTH), the 52-week high is $126.89, which is 40.18% from the current price. The 52-week low is $50.2, the current price is 80.32% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Lantheus Holdings (LNTH) a growth stock?

Lantheus Holdings (LNTH) has shown an average price growth of -3.66% over the past three years. It has received a score of 88 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Lantheus Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Lantheus Holdings 's (LNTH) price per share?

The current price per share for Lantheus Holdings (LNTH) is $90.52. The stock has seen a price change of $3.17 recently, indicating a 3.63% change. This reflects the stock's recent market performance and investor sentiment.

help

What is Lantheus Holdings (LNTH) stock price performance year to date (YTD)?

As of the latest data, Lantheus Holdings (LNTH) has a year-to-date price change of 43.45%. Over the past month, the stock has experienced a price change of -18.19%. Over the last three months, the change has been -15.53%. Over the past six months, the figure is 14.58%. Looking at a longer horizon, the five-year price change stands at 337.29%.

help

Is Lantheus Holdings (LNTH) a profitable company?

Lantheus Holdings (LNTH) has a net income of $326.66M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 54.73% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 35.31% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.3B, with a revenue growth rate of 38.65%, providing insight into the company's sales performance and growth. The gross profit is $709.54M. Operating income is noted at $364.64M. Furthermore, the EBITDA is $572.22M.

help

What is the market capitalization of Lantheus Holdings (LNTH)?

Lantheus Holdings (LNTH) has a market capitalization of $6.29B. The average daily trading volume is 90.19, indicating the stock's liquidity and investor engagement.

News

Why Lantheus Holdings Stock Won Big on Wednesday

Radiopharmaceuticals Market to Expand at a Stellar 9.8% CAGR through 2031 | SkyQuest Technology

Prostate Cancer Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 150+ Companies Working in the Domain

Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players

LANTHEUS

177LU-PNT2002

PSMA-TARGETED RADIOLIGAND THERAPY

METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

SPLASH TRIAL

Sep 15, 2024

Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024

LUTETIUM-177

CANCER TREATMENT

NEUROENDOCRINE TUMORS

PROSTATE CANCER

TARGETED RADIONUCLIDE THERAPY

Sep 9, 2024

Lutetium-177 Industry Research Report 2024: Carrier Added Lutetium-177, Non-Carrier-Added Lutetium-177 - Global Forecast 2024-2030